Svas Biosana SpA
MIL:SVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Svas Biosana SpA
MIL:SVS
|
IT |
|
Blueprint Medicines Corp
NASDAQ:BPMC
|
US |
|
Arrow Electronics Inc
NYSE:ARW
|
US |
|
Pet Valu Holdings Ltd
TSX:PET
|
CA |
|
Orecorp Ltd
ASX:ORR
|
AU |
|
Arbe Robotics Ltd
NASDAQ:ARBE
|
IL |
|
Metals X Ltd
ASX:MLX
|
AU |
|
Silver X Mining Corp
XTSX:AGX
|
CA |
|
J
|
Jumbo SA
ATHEX:BELA
|
GR |
Wall Street
Price Targets
SVS Price Targets Summary
Svas Biosana SpA
According to Wall Street analysts, the average 1-year price target for SVS is 17.44 EUR with a low forecast of 17.27 EUR and a high forecast of 17.96 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SVS's stock price target?
Price Target
17.44
EUR
According to Wall Street analysts, the average 1-year price target for SVS is 17.44 EUR with a low forecast of 17.27 EUR and a high forecast of 17.96 EUR.
What is Svas Biosana SpA's Revenue forecast?
Projected CAGR
10%
For the last 5 years the compound annual growth rate for Svas Biosana SpA's revenue is 10%. The projected CAGR for the next 3 years is 10%.
What is Svas Biosana SpA's Operating Income forecast?
Projected CAGR
11%
For the last 5 years the compound annual growth rate for Svas Biosana SpA's operating income is 15%. The projected CAGR for the next 3 years is 11%.
What is Svas Biosana SpA's Net Income forecast?
Projected CAGR
15%
For the last 5 years the compound annual growth rate for Svas Biosana SpA's net income is 19%. The projected CAGR for the next 3 years is 15%.
